Vnitr Lek 2008, 54(9):821-826

Inflammatory reaction and its importance in the course of tumour process

D. Hlávková1,*, O. Kopecký2,3, Š. Lukešová2,3
1 Ústav klinické imunologie a alergologie Lékařské fakulty UK a FN Hradec Králové, přednosta prof. RNDr. Jan Krejsek, CSc.
2 Oddělení klinické imunologie a alergologie Oblastní nemocnice Náchod, a.s., přednosta doc. MUDr. Otakar Kopecký, CSc.
3 II. interní klinika Lékařské fakulty UK a FN Hradec Králové, přednosta prof. MUDr. Jaroslav Malý, CSc.

This article gives basic information about the formation and the course of the inflammatory reaction, which is the important adaptation mechanism of the organism on the various external and internal injurants. The main attention is fixated on the role of the immune system in the course of the inflammatory reaction. It deals with the presence and the sense of the inflammatory reaction in the tumour environment in more detail. It gives the short information about the mechanisms of the antitumour defence. The influence of the inflammatory reaction on the genesis, the course and the progression of the tumour disease is discussed in the third chapter.

Keywords: inflammatory reaction; immune system; antitumour imunity; tumour microenvironment; cytokines; chemokines

Received: December 14, 2007; Accepted: April 11, 2008; Published: September 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hlávková D, Kopecký O, Lukešová Š. Inflammatory reaction and its importance in the course of tumour process. Vnitr Lek. 2008;54(9):821-826.
Download citation

References

  1. Gabay C, Kushner I. Acute-phase proteins and other systemic response to inflammation. N Engl J Med 1999; 340: 448-454. Go to original source... Go to PubMed...
  2. Krejsek J, Kopecký O. Klinická imunologie. Hradec Králové: Nucleus HK 2004: 385-405, 541-566.
  3. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-867. Go to original source... Go to PubMed...
  4. Scimone ML, Lutzky VP, Zittermann SI et al. Migration of polymorphonuclear leucocytes is influenced by dendritic cells. Immunology 2005; 114: 375-385. Go to original source... Go to PubMed...
  5. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-252. Go to original source... Go to PubMed...
  6. Luster AD. The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol 2002; 14: 129-135. Go to original source... Go to PubMed...
  7. Sozzani S, Allavena P, Vecchi A et al. Chemokines and dendritic cell traffic. J Clin Immunol 2000; 20: 151-160. Go to original source... Go to PubMed...
  8. Adema GJ, Hartgers F, Verstraten R et al. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 1997; 387: 713-717. Go to original source... Go to PubMed...
  9. Sallusto F, Lenig D, Mackay CR et al. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998; 187: 875-883. Go to original source... Go to PubMed...
  10. Tang HL, Cyster JG. Chemokine Up-regulation and activated T cell attraction by maturing dendritic cells. Science 1999; 284: 819-822. Go to original source... Go to PubMed...
  11. Zijlstra A, Seandel M, Kupriyanova TA et al. Proangiogenic role of neutrophil-like inflammatory heterophils during neovascularization induced by growth factors and human tumor cells. Blood 2006; 107: 317-327. Go to original source... Go to PubMed...
  12. Vaday GG, Lider O. Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inflammation. J Leukoc Biol 2000; 67: 149-159. Go to original source... Go to PubMed...
  13. Distler JW, Hirth A, Kurowska-Stolarska M et al. Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med 2003; 47: 149-161.
  14. Belperio JA, Keane MP, Arenberg DA et al. CXC chemokines in angiogenesis. J Leukoc Biol 2000; 68: 1-8. Go to original source... Go to PubMed...
  15. Klener P. Klinická onkologie. Praha: Galén 2002: 223-230.
  16. Hoeijmakers JHJ. Genome maintenance mechanisms for preventing cancer. Nature 2001; 411: 366-374. Go to original source... Go to PubMed...
  17. Soloski MJ. Recognition of tumor cells by the innate immune system. Curr Opin Immunol 2001; 13: 154-162. Go to original source... Go to PubMed...
  18. Caux C, Liu YJ, Banchereau J. Recent advances in the study of dendritic cells and follicular dendritic cells. Immunol Today 1995; 16: 2-4. Go to original source... Go to PubMed...
  19. Pardoll DM, Topalian SL. The role of CD4+ T cell responses in antitumor immunity. Curr Opin Immunol 1998; 10: 588-594. Go to original source... Go to PubMed...
  20. Moretta A, Bottino C, Vitale M et al. Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 1996; 14: 619-648. Go to original source... Go to PubMed...
  21. Kos FJ. Regulation of adaptive immunity by natural killer cells. Immunol Res 1998; 17: 303-312. Go to original source... Go to PubMed...
  22. Bukowski RM, Rayman P, Molto L et al. Interferon-γ and CXC chemokine induction by interleukin 12 in renal cell carcinoma. Clin Cancer Res 1999; 5: 2780-2789.
  23. Tsung K, Dolan JP, Tsung YL et al. Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection. Cancer Res 2002; 62: 5069-5075.
  24. Lukešová Š, Kopecký O. Protinádorová imunitní odpověď. Alergie 2007; 3: 241-244.
  25. Wang JM, Su S, Gong W et al. Chemokines, receptors, and their role in cardiovascular pathology. Int J Clin Lab Res 1998; 28: 83-90. Go to original source... Go to PubMed...
  26. Hofseth LJ, Wargovich MJ. Inflammation, cancer and targets of ginseng. J Nutr 2007; 137(Suppl 1): 183S-185S. Go to original source... Go to PubMed...
  27. O'Byrne KJ, Dalgleish AG. Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer 2001; 85: 473-483. Go to original source... Go to PubMed...
  28. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539-545. Go to original source... Go to PubMed...
  29. Kuper H, Adami HO, Trichopoulos D. Infections as a major preventable cause of human cancer. J Intern Med 2000; 248: 171-183. Go to original source... Go to PubMed...
  30. Wang JM, Deng X, Gong W et al. Chemokines and their role in tumor growth and metastasis. J Immunol Methods 1998; 220: 1-17. Go to original source... Go to PubMed...
  31. Schoppman SF, Birner P, Stöckl J et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 2002; 16: 947-956. Go to original source... Go to PubMed...
  32. Mudroch C, Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood 2000; 95: 3032-3043. Go to original source...
  33. O'Byrne KJ, Dalgleish AG, Browning MJ et al. The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. Eur J Cancer 2000; 36: 151-169. Go to original source... Go to PubMed...
  34. Raman D, Baugher PJ, Thu YM et al. Role of chemokines in tumor growth. Cancer Lett 2007; 256: 137-165. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.